These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 22584215

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A comparison of clinical-pathological characteristics between symptomatic and interval breast cancer.
    Meshkat B, Prichard RS, Al-Hilli Z, Bass GA, Quinn C, O'Doherty A, Rothwell J, Geraghty J, Evoy D, McDermott EW.
    Breast; 2015 Jun; 24(3):278-82. PubMed ID: 25771080
    [Abstract] [Full Text] [Related]

  • 5. The role of mammography screening attendance and detection mode in predicting breast cancer survival-is there added prognostic value?
    Biesheuvel C, Czene K, Orgeás CC, Hall P.
    Cancer Epidemiol; 2011 Dec; 35(6):545-50. PubMed ID: 21470933
    [Abstract] [Full Text] [Related]

  • 6. Comparison between screen-detected and symptomatic breast cancers according to molecular subtypes.
    Kim J, Lee S, Bae S, Choi MY, Lee J, Jung SP, Kim S, Choe JH, Kim JH, Kim JS, Lee JE, Nam SJ, Yang JH.
    Breast Cancer Res Treat; 2012 Jan; 131(2):527-40. PubMed ID: 22042364
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Update of the Swedish two-county program of mammographic screening for breast cancer.
    Tabàr L, Fagerberg G, Duffy SW, Day NE, Gad A, Gröntoft O.
    Radiol Clin North Am; 1992 Jan; 30(1):187-210. PubMed ID: 1732926
    [Abstract] [Full Text] [Related]

  • 10. Role of detection method in predicting breast cancer survival: analysis of randomized screening trials.
    Shen Y, Yang Y, Inoue LY, Munsell MF, Miller AB, Berry DA.
    J Natl Cancer Inst; 2005 Aug 17; 97(16):1195-203. PubMed ID: 16106024
    [Abstract] [Full Text] [Related]

  • 11. Survival and Disease-Free Survival by Breast Density and Phenotype in Interval Breast Cancers.
    Sala M, Domingo L, Louro J, Torá-Rocamora I, Baré M, Ferrer J, Carmona-Garcia MC, Barata T, Román M, Macià F, Castells X, CAMISS Study Group.
    Cancer Epidemiol Biomarkers Prev; 2018 Aug 17; 27(8):908-916. PubMed ID: 29853482
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Differences in Ki67 and c-erbB2 expression between screen-detected and true interval breast cancers.
    Crosier M, Scott D, Wilson RG, Griffiths CD, May FE, Westley BR.
    Clin Cancer Res; 1999 Oct 17; 5(10):2682-8. PubMed ID: 10537329
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Long-term radical prostatectomy outcomes among participants from the European Randomized Study of Screening for Prostate Cancer (ERSPC) Rotterdam.
    Loeb S, Zhu X, Schroder FH, Roobol MJ.
    BJU Int; 2012 Dec 17; 110(11):1678-83. PubMed ID: 22998182
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Socioeconomic inequalities in attending the mass screening for breast cancer in the south of the Netherlands--associations with stage at diagnosis and survival.
    Aarts MJ, Voogd AC, Duijm LE, Coebergh JW, Louwman WJ.
    Breast Cancer Res Treat; 2011 Jul 17; 128(2):517-25. PubMed ID: 21290176
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.